Sponsor:
St. Jude Children's Research Hospital
Code:
NCT04923126
Conditions
Low-Grade Glioma
Recurrent Low-Grade Glioma
Progressive Low-Grade Glioma
Eligibility Criteria
Sex: All
Age: 2 - 24
Healthy Volunteers: Not accepted
Interventions
Mirdametinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by St. Jude Children's Research Hospital on 2025-03-25.